Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Enterprise Value: 2010-2024

Historic Enterprise Value for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $3.8 million.

  • China Pharma Holdings' Enterprise Value rose 81.63% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 1213.05%. This contributed to the annual value of $3.8 million for FY2024, which is 50.18% up from last year.
  • Latest data reveals that China Pharma Holdings reported Enterprise Value of $3.8 million as of FY2024, which was up 50.18% from $2.6 million recorded in FY2023.
  • Over the past 5 years, China Pharma Holdings' Enterprise Value peaked at $18.5 million during FY2020, and registered a low of $2.6 million during FY2023.
  • Its 3-year average for Enterprise Value is $3.1 million, with a median of $2.9 million in 2022.
  • Per our database at Business Quant, China Pharma Holdings' Enterprise Value skyrocketed by 102.20% in 2020 and then plummeted by 83.75% in 2022.
  • Over the past 5 years, China Pharma Holdings' Enterprise Value (Yearly) stood at $18.5 million in 2020, then decreased by 2.62% to $18.0 million in 2021, then plummeted by 83.75% to $2.9 million in 2022, then dropped by 12.29% to $2.6 million in 2023, then skyrocketed by 50.18% to $3.8 million in 2024.